We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

60 hedge funds and large institutions have $20.4M invested in Marker Therapeutics in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

3% more funds holding

Funds holding: 58 → 60 (+2)

0.1% less ownership

Funds ownership: 3.03% → 2.93% (-0.1%)

4% less capital invested

Capital invested by funds: $21.2M → $20.4M (-$800K)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
16
Closed
6
Calls
$438K
Puts
–
Net Calls
+$438K
Net Calls Change
+$77K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$160K
2
Renaissance Technologies
Renaissance Technologies
New York
+$142K
3
GCP
GSA Capital Partners
United Kingdom
+$94.3K
4
JP Morgan Chase
JP Morgan Chase
New York
+$75.3K
5
VF
Virtu Financial
New York
+$52.8K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$298K
2
PPA
Parametric Portfolio Associates
Washington
-$179K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$101K
4
Wells Fargo
Wells Fargo
California
-$54K
5
WS
Wedbush Securities
California
-$40.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$7.25M – – –
BlackRock
2
BlackRock
New York
$3M +$160K +10,320 +5%
ACM
3
Aisling Capital Management
New York
$2.9M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.02M -$101K -6,518 -4%
State Street
5
State Street
Massachusetts
$784K -$34K -2,190 -4%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$762K +$28.3K +1,820 +4%
Northern Trust
7
Northern Trust
Illinois
$506K +$11.3K +725 +2%
Renaissance Technologies
8
Renaissance Technologies
New York
$462K +$142K +9,136 +40%
BCM
9
Bridgeway Capital Management
Texas
$287K -$38.8K -2,500 -11%
N
10
Nuveen
North Carolina
$285K -$1.15K -74 -0.4%
GCP
11
GSA Capital Partners
United Kingdom
$216K +$94.3K +6,072 +69%
VWM
12
Vigilare Wealth Management
Arizona
$206K +$20.6K +1,330 +10%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$137K -$3.28K -211 -2%
VF
14
Virtu Financial
New York
$111K +$52.8K +3,399 +80%
Charles Schwab
15
Charles Schwab
California
$107K – – –
PPA
16
Parametric Portfolio Associates
Washington
$103K -$179K -11,536 -62%
WS
17
Wedbush Securities
California
$102K -$40.5K -2,610 -27%
JP Morgan Chase
18
JP Morgan Chase
New York
$87K +$75.3K +4,851 +403%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$81K – – –
Wells Fargo
20
Wells Fargo
California
$75K -$54K -3,477 -40%
Citadel Advisors
21
Citadel Advisors
Florida
$67K -$3.42K -220 -5%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$61K – – –
RAM
23
Riggs Asset Management
Pennsylvania
$49K +$52K +3,350 New
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$46K -$574 -37 -1%
NRS
25
Neville Rodie & Shaw
New York
$44K – – –
1
2 3

MRKR Hedge Fund Activity: Q4 2020 in Review

60 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q4 2020, worth a combined $20.4M — down 3.8% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MRKR positions and 6 closed out — a net gain of 2 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $160K. The largest seller was Russell Investments Group, exiting entirely with an estimated $298K sold.

  • 60 institutional investors held Marker Therapeutics (MRKR) as of Q4 2020, up from 58 in Q3 2020.
  • Funds reported $20.4M of Marker Therapeutics stock for Q4 2020, down 3.8% quarter-over-quarter.
  • 8 funds opened new Marker Therapeutics positions in Q4 2020 and 6 closed out, a net change of +2 holders.
  • The largest Marker Therapeutics buyer in Q4 2020 was BlackRock, an estimated $160K added.
  • The largest Marker Therapeutics seller in Q4 2020 was Russell Investments Group, an estimated $298K sold.

Based on aggregated 13F filings for Q4 2020.